Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$69.1M
-22.5% from 2023
Prescriptions
3.5M
$19.76 per claim
Patients
912K
217,200 prescribers
Total spending, 2024
$69.2M
$75.80 per patient
Medicare prescription drug plans paid $69.1M for Olmesartan Medoxomil in 2024, for 3,498,420 prescriptions and refills to 912,128 patients (down 22.5% from 2023). The average cost per claim was $19.76.
Texas had the highest Medicare cost for Olmesartan Medoxomil in 2024: $7.7M for 406,390 claims, followed by California ($7.2M).
Raul A Rivera, internal medicine in Pasadena, TX, had the highest Medicare cost for Olmesartan Medoxomil in 2024: 803 claims costing $36K.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Raul A Rivera Pasadena, TX | Internal Medicine | 803 | 243 | $36K |
| Luis A Gonzalez West New York, NJ | Cardiology | 383 | 118 | $28K |
| Saugato Sanyal |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 183,155 | 2,678,014 | 688,892 | $86.2M |
| 2023 | 197,646 | 2,981,220 | 773,223 | $89.2M |
| 2024 | 217,200 | 3,498,420 | 912,128 | $69.1M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Cardiology |
| 658 |
| 212 |
| $26K |
| Gregory M Giesler Pasadena, CA | Cardiology | 916 | 229 | $24K |
| Gerald M Mancuso Kansas City, MO | Cardiology | 1,214 | 369 | $24K |
| Dale J Brent Sherman Oaks, CA | Internal Medicine | 1,289 | 135 | $24K |
| Kelvin Mai Santa Ana, CA | Internal Medicine | 1,679 | 546 | $23K |
| Edward G Carlos Mobile, AL | Internal Medicine | 1,165 | 359 | $23K |
| Vel Natesan Salisbury, MD | Internal Medicine | 673 | 180 | $23K |
| Nicholas Kondo Saratoga Springs, NY | Cardiology | 658 | 207 | $22K |
| Theodore Lawler Jr. Houston, TX | Family Practice | 624 | 190 | $22K |
| Akiva Bergman Staten Island, NY | Internal Medicine | 481 | 128 | $21K |
| Brent K Uyeno Honolulu, HI | Internal Medicine | 232 | 60 | $20K |
| Mohammad A Chaudhry Union City, NJ | Internal Medicine | 267 | 75 | $19K |
| Chang W Lee Englewood Cliffs, NJ | Internal Medicine | 186 | 52 | $18K |
| George A Younis Houston, TX | Cardiology | 837 | 252 | $18K |
| Wei Y Sun New York, NY | Nephrology | 3,560 | 521 | $18K |
| Mustali M Dohadwala Christiansburg, VA | Cardiology | 573 | 166 | $18K |
| Randeep Suneja Katy, TX | Cardiology | 688 | 225 | $17K |
| Daniel D Vanhamersveld Sacramento, CA | Cardiology | 862 | 293 | $17K |
| Shu May Lee Daly City, CA | Internal Medicine | 355 | 98 | $16K |
| Mark A St.Pierre North Little Rock, AR | Cardiology | 883 | 270 | $16K |
| Randall S Williams Chico, CA | General Practice | 634 | 192 | $16K |
| Manu Sehgal Milford, DE | Internal Medicine | 492 | 149 | $16K |
| Hugo M Toro Katy, TX | Internal Medicine | 239 | 84 | $15K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Glenmark Pharma GLENMARK.NS | 1,553,525 | $30.6M |
| Macleods Pharma | 609,518 | $13.1M |
| Ascend Laborato ALKEM.NS | 470,315 | $10.1M |
| Accord Healthca | 257,882 | $4.6M |
| Alembic Pharmac | 169,517 | $3.1M |
| Quallent Pharma | 100,567 | $2.5M |
| Solco Healthcar | 159,874 | $2.0M |
| Aurobindo Pharm AUROPHARMA.NS | 68,779 | $1.3M |
| Sciegen Pharmac | 50,226 | $839K |
| Lannett Co. Inc | 34,915 | $584K |
| Tris Pharma Inc | 16,582 | $248K |
| Rising Pharm | 6,037 | $117K |
| Novadoz Pharmac | 1,427 | $24K |
| Micro Labs USA, | 262 | $5,598 |
| Lifestar Pharma | 32 | $557 |